University of Notre Dame
400 Main Building, Notre Dame, IN, 46556, USA
Overview
University of Notre Dame is a private Catholic institution offering a wide range of academic programs, including undergraduate, graduate, and professional degrees across various fields of study such as business, engineering, humanities, and sciences. Known for its strong commitment to faith, academic excellence, and research, the university fosters a vibrant community for both students and faculty. Notre Dame combines a rich tradition of service and leadership with a focus on intellectual development and innovation.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 10
Sector focus
- Education
- Higher Education
- Universities
Investment portfolio
- Torigen Pharmaceuticals
Participated · Series A · Nov 2022
Torigen Pharmaceutical is a commercial-stage animal health biologics company that aims to innovate pet cancer treatment by leveraging the pet’s immune system to create personalized cancer immunotherapies. Led by CEO Ashley Kalinauskas, the company is a spin-out from the University of Notre Dame and is based in Farmington, CT. Torigen is focused on developing new biologic products to treat cancer in companion animals. The company says it will use the proceeds from its latest financing to continue to develop new products and expand its salesforce. The company is described as commercial-stage. The recent financing provides additional capital to support its product development and commercial expansion.